Does CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55 Cause Hepatic function abnormal? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Hepatic function abnormal have been filed in association with CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55. This represents 12.2% of all adverse event reports for CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55.
10
Reports of Hepatic function abnormal with CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55
12.2%
of all CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55 reports
5
Deaths
7
Hospitalizations
How Dangerous Is Hepatic function abnormal From CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55?
Of the 10 reports, 5 (50.0%) resulted in death, 7 (70.0%) required hospitalization, and 5 (50.0%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55 Cause?
Diarrhoea (11)
Pyrexia (9)
Constipation (7)
Pneumonia (7)
Alanine aminotransferase increased (6)
Anaemia (6)
Nausea (6)
Drug-induced liver injury (5)
Fall (5)
Thrombocytopenia (5)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)